A Few Millimeters Matter: Why Image-Guided Hip Injections Can Significantly Affect Accuracy and Outcomes

Posted on: 06-Aug-2026

A few millimeters may not sound significant until you're talking about a hip injection. Unlike more accessible joints, the hip sits deep beneath layers of muscle, making precise needle placement surprisingly challenging. Discover why specialists increasingly rely on imaging technology to improve accuracy and give treatments the best opportunity to work.

Why the Hip Is Such a Difficult Target

Unlike a knee or shoulder, the hip joint cannot be reliably located through palpation alone. It sits several inches beneath the skin, surrounded by major muscles, nerves, and blood vessels, with no easily felt bony landmark marking the exact location of the joint capsule. This depth and the proximity to neurovascular structures are precisely why injections guided only by anatomical landmarks carry more room for error than injections elsewhere in the body.

What the Accuracy Numbers Actually Show

The gap between guided and unguided hip injections is not subtle. Landmark-based, or blind, hip injections have reported accuracy rates ranging from roughly 50 to 80 percent, depending on the technique and the experience of the clinician performing it.¹ Image-guided injections, by contrast, have been shown in multiple studies to reach accuracy rates between 97 and 100 percent.² That difference means a substantial share of blind hip injections may never actually reach the joint space at all, delivering medication into surrounding muscle or soft tissue instead of the site it was intended to treat.

Ultrasound Versus Fluoroscopy: Different Tools, Similar Precision

Both ultrasound and fluoroscopic guidance dramatically outperform blind technique, though each comes with its own tradeoffs. A comparative study found that patients strongly preferred ultrasound guidance over fluoroscopy, rating it significantly more convenient and less painful, while both methods achieved comparably high accuracy.³ Fluoroscopy involves radiation exposure and contrast dye but offers excellent bony detail, while ultrasound avoids radiation entirely and allows real-time visualization of soft tissue as the needle advances. The right choice often depends on the specific structure being targeted and the clinical question being answered.

Why Precision Becomes Even More Important With Advanced Treatments

Accuracy matters for every type of hip injection, but it becomes especially consequential as treatment options grow more specialized, and research shows the benefit of these treatments is far from uniform. A prospective study evaluating platelet-rich plasma added during hip arthroscopy for labral tears found that PRP did not improve outcomes compared to a standard control injection, with the PRP group actually reporting slightly higher pain scores at two years.⁴ A separate randomized trial testing PRP during arthroscopic surgery for femoroacetabular impingement likewise found no meaningful difference between PRP and a saline placebo at two years.⁵

The picture looks different outside the operating room, however. A pilot study of PRP injections for early-stage hip osteoarthritis, where the joint space was still well preserved, found promising improvements in pain and function, and separate reviews have found PRP favorable for extra-articular conditions like greater trochanteric pain syndrome and hamstring injuries.⁶ Viscosupplementation has produced similarly mixed results in clinical trials for hip osteoarthritis.⁷ Across all of these findings, one theme holds steady: precise delivery into the intended target, whether that is the joint space or a specific soft tissue structure, is foundational to giving any treatment, and any research evaluating it, a fair chance to show a true effect.

The Bottom Line on Injection Precision

A few millimeters might sound trivial, but in a joint as deep and densely surrounded as the hip, that margin is often the difference between a treatment that reaches its target and one that does not. Whether the injection involves a standard corticosteroid, hyaluronic acid, platelet-rich plasma, or another regenerative option, image guidance gives both the patient and the clinician confidence that the treatment actually went where it was supposed to go.

If you are considering a hip injection of any kind, it is worth asking how that injection will be guided and confirmed before the appointment, since that detail can shape the outcome as much as the treatment itself.

Frequently Asked Questions

1. Are blind hip injections less accurate than image-guided ones?
Yes. Studies have found that landmark-guided hip injections succeed in reaching the joint space roughly 50 to 80 percent of the time, compared to 97 to 100 percent accuracy with image guidance.⁸
2. What is the difference between ultrasound and fluoroscopy for hip injections?
Ultrasound uses real-time sound wave imaging and avoids radiation, while fluoroscopy uses live X-ray imaging and offers excellent visualization of bone. Both have demonstrated high accuracy compared to blind technique.
3. Does PRP work better than hyaluronic acid for hip osteoarthritis?
Research comparing the two has produced mixed results, with some studies favoring PRP for longer-lasting pain relief and others finding no significant difference, so individual factors often guide which option makes sense.
4. Why does injection accuracy matter more for regenerative treatments like PRP?
Regenerative treatments are designed to act directly within the joint space, so if the injection misses that target, the treatment has little opportunity to produce its intended effect regardless of what is being injected.
5. Is viscosupplementation effective for hip osteoarthritis?
Clinical trial evidence on hyaluronic acid injections for hip osteoarthritis is mixed, with some studies showing modest short-term benefit and others finding no significant difference compared to placebo.

Reference Links:

AUTHOR: Benjamin D. Kuhns, MD, MS – Orthopedic Hip Surgeon & Research Director

Benjamin D. Kuhns, MD, MS is a board-certified orthopedic surgeon and Director of Research at the American Hip Institute in Des Plaines and Chicago, Illinois. He specializes in comprehensive hip care, including hip preservation, arthroscopy, open osteotomies, and primary and revision anterior approach hip arthroplasty. Dr. Kuhns also incorporates regenerative medicine techniques into personalized treatment strategies designed to restore function and accelerate return to activity.

Credentials & Recognition

Dr. Kuhns completed his Bachelor of Arts at Colgate University with a major in chemistry and a minor in history, followed by a Master of Science in Neuroscience from Northwestern University. He earned his medical degree from Case Western Reserve University School of Medicine, graduating with distinction in research and being inducted into the Alpha Omega Alpha honor society. He then completed orthopedic residency training at the University of Rochester Medical Center, where he received the Kenneth DeHaven Research Award for work linking femoroacetabular impingement to hip osteoarthritis. Following residency, Dr. Kuhns pursued fellowship training in adult hip preservation and reconstruction at The Steadman Clinic and completed advanced hip preservation training at the American Hip Institute. He has authored more than 40 peer-reviewed articles and book chapters on hip dysfunction and surgical management.

Clinical Expertise

Dr. Kuhns’ clinical focus includes non-operative management of hip pain through targeted physical therapy and injections, complex primary and revision hip arthroscopy, open hip preservation including periacetabular and femoral osteotomies, and robotic anterior approach total hip arthroplasty. In his role as a surgeon and researcher, he collaborates closely with patients to craft customized treatment plans aimed at optimizing functional outcomes and helping individuals return to the activities they enjoy, regardless of age. He is an active member of professional organizations, including the American Academy of Orthopaedic Surgeons and The Hip Preservation Society (ISHA).

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Kuhns or another qualified orthopedic specialist at the American Hip Institute.

AUTHOR: Etan P. Sugarman, M.D., FAAOS - Orthopedic Joint Preservation & Sports Medicine Surgeon

Etan P. Sugarman, M.D., FAAOS is a board-certified orthopedic surgeon specializing in joint preservation, hip arthroscopy, hip replacement, sports medicine, and regenerative medicine. He serves as Director of Joint Preservation at the American Hip Institute, where he focuses on advanced, minimally invasive solutions for complex hip, shoulder, and knee conditions to help patients return to active lifestyles.

Credentials & Recognition

Dr. Sugarman earned his undergraduate degree from New York University, where he was recognized for academic excellence. He received his medical degree from the University of Illinois College of Medicine and completed his orthopedic surgery residency at the University of Michigan, where he served as Chief Resident. Following residency, Dr. Sugarman completed fellowship training in adult hip reconstructive and preservation surgery at the world-renowned Steadman Philippon Research Institute in Vail, Colorado, an experience that deepened his expertise in advanced hip arthroscopy, osteotomy, and joint preservation techniques. He is a Fellow of the American Academy of Orthopaedic Surgeons (FAAOS) and is actively involved in hip preservation research, clinical innovation, and education for both patients and the orthopedic community.

Clinical Expertise

Dr. Sugarman’s clinical practice encompasses the full spectrum of hip care, ranging from non-operative management, including injections and physical therapy, to cutting-edge surgical interventions. His areas of expertise include hip arthroscopy for femoroacetabular impingement and labral tears, periacetabular osteotomy for hip dysplasia, complex revision surgery, and anterior approach total hip arthroplasty. He emphasizes a patient-centered approach, integrating evidence-based surgical techniques with individualized rehabilitation plans to promote optimal recovery and long-term function. Dr. Sugarman also contributes to peer-reviewed scientific literature and is dedicated to advancing the field of hip preservation and reconstruction.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Sugarman or another qualified orthopedic specialist at the American Hip Institute.